← Back to Search

Local Anesthetic

Liquid Lidocaine for Stroke

Phase 2
Waitlist Available
Led By Adam H de Havenon, MD
Research Sponsored by University of Utah
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 90 days
Awards & highlights

Summary

This trial will test whether SPG block can relieve post-stroke headache.

Eligible Conditions
  • Stroke
  • Headache

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~90 days
This trial's timeline: 3 weeks for screening, Varies for treatment, and 90 days for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Change in Number of Migraine Headaches During Treatment Phase
Secondary study objectives
Adverse effect
Numeric Pain Rating Scale

Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: Liquid LidocaineExperimental Treatment1 Intervention
The investigational treatment is 1.5 mL of aqueous 2% lidocaine.
Group II: Sham PlaceboPlacebo Group1 Intervention
The placebo arm is 1.5mL of aqueous of saline.

Find a Location

Who is running the clinical trial?

University of UtahLead Sponsor
1,127 Previous Clinical Trials
1,793,177 Total Patients Enrolled
19 Trials studying Stroke
3,437 Patients Enrolled for Stroke
Adam H de Havenon, MDPrincipal InvestigatorUniversity of Utah
1 Previous Clinical Trials
100 Total Patients Enrolled
~6 spots leftby Sep 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top